These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 228312)

  • 41. Direct effect of a nomifensine derivative on dopamine receptors.
    Poat JA; Woodruff GN; Watling KJ
    J Pharm Pharmacol; 1978 Aug; 30(8):495-7. PubMed ID: 28397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of brain catecholamines in the regulation of ACTH secretion.
    Van Loon GR
    Adv Neurol; 1974; 5():479-86. PubMed ID: 4374068
    [No Abstract]   [Full Text] [Related]  

  • 43. Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release.
    Hoffmann IS; Talmaciu RK; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Aug; 238(2):437-46. PubMed ID: 2942676
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of reserpine on the inhibition of prolactin released from different pituitary constructs in vitro by dopamine, bromocriptine and apomorphine.
    Dutt A; Juneja HS
    Endocr Res; 1992; 18(4):307-20. PubMed ID: 1473523
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparative review of the pharmacology of nomifensine.
    Hoffmann I
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):69S-75S. PubMed ID: 911654
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reserpine inhibits rat anterior pituitary hormone secretion in vitro: effects on prolactin and ACTH and ultrastructural observations.
    Login IS; Cronin MJ; Lamberts SW; Valdenegro CA; MacLeod RM
    Brain Res; 1983 Jan; 260(1):99-106. PubMed ID: 6297687
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The dopaminergic regulation of anterior pituitary 45Ca2+ homeostasis and prolactin secretion.
    Schrey MP; Clark HJ; Franks S
    J Endocrinol; 1986 Mar; 108(3):423-9. PubMed ID: 3486242
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of debrisoquin and bretylium on adrenergic nerves as revealed by fluorescence histochemistry.
    Malmors T; Abrams WB
    J Pharmacol Exp Ther; 1970 Jul; 174(1):99-110. PubMed ID: 4316536
    [No Abstract]   [Full Text] [Related]  

  • 49. 4-Phenyltetrahydroisoquinoline, but not nomifensine or cocaine, inhibits methamphetamine-induced dopamine release.
    Tateyama M; Nagao T; Ohta S; Hirobe M; Ono H
    Eur J Pharmacol; 1993 Aug; 240(1):51-6. PubMed ID: 8405121
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of norepinephrine and catecholamine-depleting agents on the synthesis and release of prolactin and growth hormone.
    MacLeod RM
    Endocrinology; 1969 Nov; 85(5):916-23. PubMed ID: 5818077
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of nomifensine on the isolated vas deferens of the rat.
    Tayo FM
    Arch Int Pharmacodyn Ther; 1979 Jul; 240(1):94-102. PubMed ID: 508001
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nomifensine antagonizes the ouabain-induced increase in dopamine metabolites in cerebrospinal fluid of the rat.
    Elghozi JL; Le Quan-Bui KH; Devynck MA; Meyer P
    Eur J Pharmacol; 1983 Jun; 90(2-3):279-82. PubMed ID: 6192001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of the ergot derivative lisuride hydrogen maleate on serum prolactin concentrations in female rats.
    Gräf KJ; Neumann F; Horowski R
    Endocrinology; 1976 Mar; 98(3):598-605. PubMed ID: 1261489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Control of pituitary functions of synthesis and release of prolactin and growth hormone by gonadal steroids in female and male rats.
    Yamamoto K; Kasai K; Ieiri T
    Jpn J Physiol; 1975; 25(5):645-58. PubMed ID: 1232474
    [No Abstract]   [Full Text] [Related]  

  • 55. In vivo effects of benztropine and nomifensine on dopamine and noradrenaline terminals in rat brain.
    Broch OJ
    Eur J Pharmacol; 1979 Oct; 58(4):419-24. PubMed ID: 510376
    [No Abstract]   [Full Text] [Related]  

  • 56. The action of norepinephrine in the rat hippocampus. II. Activation of the input pathway.
    Segal M; Bloom FE
    Brain Res; 1974 May; 72(1):99-114. PubMed ID: 4364477
    [No Abstract]   [Full Text] [Related]  

  • 57. delta 9-Tetrahydrocannabinol antagonism of the anterior pituitary response to estradiol in immature female rats.
    Murphy LL; Rodriguez de Fonseca F; Steger RW
    Steroids; 1991 Feb; 56(2):97-102. PubMed ID: 1850566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Acute effects of nomifensine on brain levels of NE and DA in rats].
    Ravizza L; Torre E; Bogetto F; Rebaudengo P
    Minerva Psichiatr; 1980; 21(1):45-7. PubMed ID: 7464482
    [No Abstract]   [Full Text] [Related]  

  • 59. Potent antidopaminergic activity of estradiol at the pituitary level on prolactin release.
    Raymond V; Beaulieu M; Labrie F; Boissier J
    Science; 1978 Jun; 200(4346):1173-5. PubMed ID: 418505
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Different adaptive responses by rat striatal dopamine synthetic and receptor mechanisms after repeated treatment with d-amphetamine, methylphenidate and nomifensine.
    Algeri S; Brunello N; Vantini G
    Pharmacol Res Commun; 1980 Jul; 12(7):675-81. PubMed ID: 6105682
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.